×






PieTrader

Democratizing hedge fund level analysis tools for everyone

search

(contoh: TLKM)



About
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, food supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd..

Info Profile
Name Millennium Pharmacon International Tbk.
Sector Healthcare
Industry Pharmaceuticals & Health Care Research
Code F2
Latest Quarterly 12/31/2024

Shareholder Tracker
Name Latest % A Month Ago %
Pharmaniaga International Corporation Sdn. Bhd. 73.43 73.43
Public < 5% 16.85 16.85
PT. Danpac Pharma 9.72 9.72
Others 0.0 0.0
Shareholder Class
Classification Latest % Previous %
Institution 83.15 83.15
Retail 16.85 16.85
Individual 0.0 0.0
Management 0.0 0.0
Revenue Source 2023 2022
Prescription Medicine 69.0% 72.5%
Medical Devices 25.2% 21.1%
Non-prescription Medicine 5.8% 6.4%
Others 0.0% 0.0%
Other 0.0% 0.0%

Revenue Region 2023 2022
Indonesia 100.0% 100.0%
Others 0.0% 0.0%



Valuation Ratios Rank
P/S 0.04 # 1 / 15
EV_EBITDA 13.24 # 7 / 15
PER 8.99 # 2 / 15
PBV 0.53 # 3 / 15
DER 5.27 # 13 / 15

Profitability Ratios Rank
NPM % 0.4 # 10 / 15
ROA % 1.0 # 9 / 15
ROE % 6.0 # 10 / 15


Year DPS Yield [%]
2024 2.5 2.1
2023 2.0 1.3
2022 1.0 0.3
2021 0.5 0.4
2020 1.0 1.0
Stock SDPC SDPC

Timeframe Performance
1W % 0.0
1Mo % -7.9
3Mo % -11.4
1Yr % -17.6

Pivot Points
R2 136
R1 128
S1 113
S2 106





Link download Laporan Keuangan emiten

Peers Comparison

Stocks PER Market Cap EV Revenue EBITDA Net Profit
SDPC 8.99 149 B 1.59 T 3.92 T 120 B 17 B
KLBF 17.37 55.31 T 55.45 T 32,600 B 5,070 B 3,240 B
SIDO 14.09 16.65 T 16.25 T 3,920 B 1,580 B 1,170 B
TSPC 8.02 10.82 T 9.70 T 13,700 B 2,110 B 1,450 B
SOHO 19.76 7.93 T 10.21 T 10,100 B 618 B 463 B
KAEF -4.16 2.20 T 12.80 T 10,500 B -9 B -562 B